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Kinetic studyAbstract In the continuation of our work to synthesize enzyme inhibitors, we synthesized 3,4,5-tri
hydroxybenzohydrazones (1–19) from 3,4,5-trihydroxybenzohydrazide, which were obtained from
methyl 3,4,5-trihydroxybenzoate by reﬂuxing with hydrazine hydrate. All the synthesized com-
pounds were characterized by different spectroscopic methods. The synthesized compounds were
evaluated for urease inhibition and showed excellent results, close to the standards thiourea. The
kinetic studies on the ﬁve most active compounds 6, 10, 14, 16 and 18 were carried out to determine
their mode of inhibition and dissociation constant Ki. The compounds 6 and 16 were found to be
competitive inhibitors with Ki values 19.1 and 10.53 lM, respectively, while the compounds 10, 14
and 18 were found to be mixed-type of inhibitors with Ki values in the range of 18.4–21.7 lM.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Applications of benzohydrazones are reported in medicinal and
analytical chemistry (Cimerman et al., 2000; Taha et al., 2014;
Tarafder et al., 2002). Benzohydrazones having heterocyclic
rings were reported to have antiglycation, anticonvulsant,
Phosphodiesterase-1 inhibitors, antiproliferative, antifungal
and anti-HIV activities (Kabak et al., 1999; Ku¨c¸u¨kgu¨zel et al.,
2004; Khan et al., 2014a; Jamil et al., 2015; Pandeya et al.,
1999). Several benzohydrazones reported interesting bioactivi-
ties, such as antifungal, anticonvulsant, anti-inﬂammatory,urnal of
Scheme 1 Synthesis of 3,4,5-Trihydroxybenzohydrazones (1–19).
2 M. Taha et al.antibacterial, antimalarial, antiplatelets, analgesic, antitubercu-
losis, antioxidant (Loncle et al., 2004; Ku¨c¸u¨kgu¨zel et al., 2003;
Todeschini et al., 1998; Melnyk et al., 2006; Lima et al., 2000;
Cunha et al., 2003; Kaymakc¸ıog˘lu et al., 2006; Aziz et al.,
2014), antileishmanial, insecticidal, immunoconjugates,
antimycobacterial, adriamycin proteinase inhibition and activ-
ity against protozoan parasite (Sawada et al., 2003; Taha et al.,
2013; Ku¨c¸u¨kgu¨zel and Rollas, 2002; Greenﬁeld et al., 1990;
Caffery et al., 2002). Other benzohydrazone derivatives have
reported b-glucuronidase (Jamil et al., 2014) and a-
glucosidase inhibition activity (Taha et al., 2015a). On the otherTable 1 In vitro urease inhibition 1–19.
Compound R IC50 (lM± SEM
a) Com
1
Cl
1'
4'
5'
6' 2'
37.30 ± 1.4 11
2
1'
3'5'
6'
OCH3
2'
57.40 ± 2.2 12
3
N
1'
3'5'
6'
4'
47.40 ± 1.8 13
4
S1'
2'
3'
4'
38.40 ± 1.4 14
5
1'
3'5'
6'
F
2'
39.70 ± 1.4 15
6
O1'
2'
3'
4'
28.90 ± 1.2 16
7
CH3
1'
4'
5'
6' 2'
38.30 ± 1.5 17
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broad range of bioactivities, including antiurease (Taha et al.,
2015b), and antibacterial activities (Imran et al., 2014).
Hydrazine derivatives also have several commercial applica-
tions (Ragnarsson, 2001).
Urease (E.C 3.5.1.5) plays an important role in the viru-
lence of some bacterial pathogens as well as determinant in
pathogenesis of many diseases in human. It is involved in
the production of infectious stones; add to the pathogenesis
of urolithiasis, pyelonephritis, and hepatic encephalopathy
(Weatherburn, 1967). The urease results in pathologies bypound R IC50 (lM± SEM
a)
NO2
1'
4'
5'
6' 2'
40.20 ± 1.6
1'
3'5'
6'
Cl
2'
53.90 ± 1.8
1'
3'5'
6'
CH3
2'
55.40 ± 1.9
F
1'
4'
5'
6' 2'
30.20 ± 1.3
1'
3'5'
6'
4'
CH3
54.00 ± 1.8
OH
1'
4'
5'
6' 2'
27.20 ± 1.2
OCH3
1'
4'
5'
6' 2'
83.20 ± 2.2
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Table 1 (continued)
Compound R IC50 (lM± SEM
a) Compound R IC50 (lM± SEM
a)
8
OH
1'
5'
6' 2'
OCH3
50.80 ± 1.9 18
1'
3'5'
6'
4'
F
30.10 ± 1.2
9 N
1'
5'
6' 2'
3'
42.80 ± 1.5 19
1'
3'5'
6' 2'
OO
CH3
48.80 ± 1.6
10
1'
3'5'
6'
4'
NO2
30.80 ± 1.2 Standard Thioureab 21.20 ± 1.30
a Standard deviation.
b Standard drug.
A B
1/Substrate (urea)
-2 -1 0 1 2
1/
V
-0.4
-0.2
0
0.2
0.4
35.0000
30.0000
25.0000
20.0000
0.0000
Inhibitor (compound 6)
-40 -30 -20 -10 0 10 20 30 40
Sl
op
e 
(K
m
/V
m
ax
)
-0.2
-0.1
0
0.1
0.2
Figure 1 The inhibition of urease by compound 6. (A) Lineweaver–Burk plot of reciprocal of rate of reaction (velocities) vs reciprocal of
substrate (urea) in the absence (4), and in presence of 20 lM (n), 25 lM (h), 30 lM (d), and 35 lM (s) of compound 6. (B) Secondary
replot of Lineweaver–Burk plot between the slopes of each line on Lineweaver–Burk plot vs different concentration of compound 6.
Synthesis of 3,4,5-trihydroxybenzohydrazone and evaluation of inhibition potential 3Helicobacter pylori (HP), by helping the bacteria to endure
at low pH of the stomach during colonization. Thus, it plays
a vital role in the pathogenesis of the gastric as well as pep-
tic ulcers which may cause cancer (Devesa et al., 1998).
Additionally, urease causes kidney stones formation but also
engages in the growth of urolithiasis, pyelonephritis, and
hepatic encephalopathy (Martelli et al., 1981). In agriculture,
during urea fertilization, high urease activity results in signif-
icant environmental and economic losses by discharge of
abnormally huge amounts of ammonia in atmosphere. This
also leads to plant damage by depriving them from essential
nutrients, secondary ammonia toxicity and increase in pH of
the soil (Mobley and Hausinger, 1989). Urease inhibition,Please cite this article in press as: Taha, M. et al., Synthesis of 3,4,5-trihydroxybenzoh
Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.036therefore, has been identiﬁed as ﬁrst line of treatment of dis-
eases caused by ureolytic bacteria (Saify et al., 2014).
Recently reported urease inhibitors are hydroxamate com-
plex (Cheng et al., 2014), homoserine lactone derivative
(Czerwonka et al., 2014), thiophosphoric triamides
(Ludden et al., 2000), oxadiazoles derivatives (Akhtar
et al., 2014), thioureas (Khan et al., 2014b), ethyl
4-(3-benzothioureido) benzoates derivatives (Saeed et al.,
2014), Oxindole derivatives (Taha et al., 2015c) and thiobar-
bituric acid derivatives (Khan et al., 2014c). However, cur-
rently available inhibitors are not efﬁcient and the full
potential of urease inhibition is yet to be discovered (Font
et al., 2008).ydrazone and evaluation of their urease inhibition potential. Arabian Journal of
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Figure 2 The inhibition of urease by compound 10. (A) Lineweaver–Burk plot of reciprocal of rate of reaction (velocities) vs reciprocal
of substrate (urea) in the absence (4), and in presence of 20 lM (n), 30 lM (h), 40 lM (d), and 50 lM (s) of compound 10. (B)
Secondary replot of Lineweaver–Burk plot between the slopes of each line on Lineweaver–Burk plot vs different concentration of
compound 10.
Table 2 The mode of inhibition of compounds 6, 10, 14, 16,
and 18.
Compounds Ki (lM) Type of inhibition
6 19.10 ± 0.007 Competitive inhibition
10 19.90 ± 0.003 Mixed-type inhibition
14 21.71 ± 0.007 Mixed-type inhibition
16 10.53 ± 0.02 Competitive inhibition
18 18.41 ± 0.003 Mixed-type inhibition
Standard (thiourea) 20.01 ± 0.02 Competitive inhibition
4 M. Taha et al.2. Experimental
2.1. General experimental
Melting points were determined on a Bu¨chi 434 melting point
apparatus and are uncorrected. NMR was performed onA
1/Substrate (urea)
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Figure 3 The inhibition of urease by compound 14. (A) Lineweaver–
of substrate (urea) in the absence (n), and in presence of 20 lM (h), 30
Lineweaver–Burk plot between the slopes of each line on Lineweaver–
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CHN analyses were determined on a Carlo Erba
Strumentazion-Mod-1106, Italy instrument. Infrared (IR)
spectra were recorded on a JASCO IR-A-302 spectrometer.
Electron impact mass spectra (EI MS) were recorded on a
Finnigan MAT-311A, Germany spectrometer. Thin layer
chromatography (TLC) was performed on precoated silica
gel glass plates (Kieselgel 60, 254, E. Merck, Germany).
2.2. Experimental protocol
2.2.1. General procedure for the synthesis of 3,4,5-
trihydroxybenzohydrazide
The methyl 3,4,5-trihydroxybenzoate was reﬂuxed with the
mixture of hydrazine hydrated (5 mL) and methanol (15 mL)
for 6 h. The excess hydrazine and methanol were evaporated
to obtain crude product which was recrystallized by methanol
and yielded 92% pure 3,4,5-trihydroxybenzohydrazide.B
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Burk plot of reciprocal of rate of reaction (velocities) vs reciprocal
lM (d), and 40 lM (s) of compound 14. (B) Secondary replot of
Burk plot vs different concentration of compound 14.
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Figure 4 The inhibition of urease by compound 16. (A) Lineweaver–Burk plot of reciprocal of rate of reaction (velocities) vs reciprocal
of substrate (urea) in the absence (m), and in presence of 10 lM (4), 15 lM (n), 20 lM (h), 25 lM (d), and 30 lM (s) of compound 16.
(B) Secondary replot of Lineweaver–Burk plot between the slopes of each line on Lineweaver–Burk plot vs different concentration of
compound 16.
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Figure 5 The inhibition of urease by compound 18. (A) Lineweaver–Burk plot of reciprocal of rate of reaction (velocities) vs reciprocal
of substrate (urea) in the absence (n), and in presence of 20 lM (h), 30 lM (d), and 40 lM (s) of compound 18. (B) Secondary replot of
Lineweaver–Burk plot between the slopes of each line on Lineweaver–Burk plot vs different concentration of compound 18.
Synthesis of 3,4,5-trihydroxybenzohydrazone and evaluation of inhibition potential 52.2.2. General procedure for the synthesis of 3,4,5-
trihydroxybenzohydrazone derivatives
The 3,4,5-trihydroxybenzohydrazone derivatives were synthe-
sized by reﬂuxing in methanol a mixture of 2 mmol each of
3,4,5-trihydroxybenzohydrazide with different aldehydes and
catalytic amount of acetic acid for 3 h. After the completion
of the reaction, the solvent was evaporated by vacuum to
afford crude products which were further recrystallized in
methanol and got needle like pure product in most of the cases
in good to excellent yields.
2.2.2.1. (E)-N0-(3-chlorobenzylidene)-3,4,5-trihydroxybenzo-
hydrazide (1). Yield: 82%. m.p. 172–173 C; 1H NMR
(500 MHz, DMSO-d6): d 11.64 (s, 1H, NH), 9.64 (br. s, 3H,
OH), 8.34 (s, 1H, N‚CHAAr), 7.77 (s, 1H), 7.66 (d, 1H,
J= 5.5 Hz), 7.06 (dd, 1H, J= 5.5, 2.0 Hz), (d, 1H,
J= 2.0 Hz), 6.91(s, 2H); Anal. Calcd for Anal. Calcd forPlease cite this article in press as: Taha, M. et al., Synthesis of 3,4,5-trihydroxybenzoh
Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.036C14H11ClN2O4, C = 54.83, H = 3.62, N = 9.13, Found
C = 54.84, H = 3.63, N = 9.15; EI MS m/z (% rel. abund.):
308 (M+ 2, 6), 306 (M+, 20).
2.2.2.2. (E)-3,4,5-trihydroxy-N0-(4-methoxybenzylidene)ben-
zohydrazide (2). Yield: 78%. m.p. 174–175 C; 1H NMR
(500 MHz, DMSO-d6): d 11.70 (s, 1H, NH), 11.40 (s, 1H,
OH) 9.88 (br. s, 3H, OH), 831 (s, 1H, N‚CHAAr), 7.92 (d,
2H, J= 8.5 Hz), 7.06 (d, 2H, J= 8.5 Hz), 6.90 (s, 2H), 3.81
(s, 3H, OCH3); Anal. Calcd for Anal. Calcd for
C15H14N2O5, C = 59.60, H = 4.67, N = 9.27, Found
C = 59.61, H = 4.68, N = 9.26; EI MS m/z (% rel. abund.):
302.
2.2.2.3. (E)-3,4,5-trihydroxy-N0-(pyridin-2-ylmethylene)benzo-
hydrazide (3). Yield: 84%. m.p. 175–176 C; 1H NMR
(500 MHz, DMSO-d6): d 11.48 (s, 1H, NH), 10.54 (s, 1H,ydrazone and evaluation of their urease inhibition potential. Arabian Journal of
Table 3 Variation in the IR and H NMR of all functional groups present in compound (1–19).
Compound R IR (cm1) 1H NMR
1 3-Cl 715 Due to chlorine electronegativity adjacent proton shifted to downﬁeld
2 4-OCH3 1210 The presence of OCH3 at d 3.81
3 2-C‚NAC 1640 Due to nitrogen electronegativity adjacent proton shifted to downﬁeld
4 Thiophene 540 Due to small ring its proton coupling constants are 4–5 Hz only
CASAC
5 4-F 1340 Its adjacent proton gave multiple splitting due to ﬂuorine
6 Furan 1230 Due to small ring its proton coupling constants are 4–5 Hz only
CAOAC
7 3-CACH3 2950 The presence of CH3 at d 2.36
1440
8 3-OH 3320 The presence of OH d 9.20 and at 3.86 for OCH3
4-OCH3 1190
9 4-C‚NAC 1635 Due to nitrogen electronegativity adjacent proton shift to downﬁeld
10 2-NO2 1460 Due to nitrogen electronegativity adjacent proton shift to downﬁeld
11 3-NO2 1430 Due to nitrogen electronegativity adjacent proton shift to downﬁeld
12 4-Cl 740 Due to chlorine electronegativity adjacent proton shift to downﬁeld
13 4-CH3 2930 The presence of CH3 at d 2.33
1460
14 3-F 1342 Its adjacent proton gave multiple splitting due to ﬂuorine
15 2-CH3 2937 The presence of CH3 at d 2.35
1452
16 3-OH 3340 The presence of OH d 10.21
17 4-OCH3 1190 The presence of OCH3 at d 3.80
18 2-F 1310 Its adjacent proton gave multiple splitting due to ﬂuorine
19 4-COOMe 1710 The presence of OCH3 at d 3.84
1220
6 M. Taha et al.OH), 9.70 (br. s, 2H, OH), 9.06 (d, 1H, J= 2.0 Hz), 8.70 (dd,
1H, J= 7.0, 2.0 Hz), 8.41 (dd, 2H, J= 2.0, 6.5 Hz), 831
(s, 1H, N‚CHAAr), 7.82 (dd, 1H, J= 7.0, 6.5 Hz), 6.94
(s, 2H); Anal. Calcd for Anal. Calcd for C13H11N3O4,
C = 57.14, H = 4.06, N = 15.38, Found C = 57.15,
H = 4.08, N = 15.37; EI MS m/z (% rel. abund.): 273.
2.2.2.4. (E)-3,4,5-trihydroxy-N0-(thiophen-2-ylmethylene)ben-
zohydrazide (4). Yield: 85%. m.p. 179–180 C; 1H NMR
(500 MHz, DMSO-d6): d 11.48 (s, 1H, NH), 9.60 (br. s, 3H,
OH), 8.61 (s, 1H, N‚CHAAr), 7.49 (d, 1H, J= 5.0 Hz),
7.41 (d, 1H, J= 3.0 Hz), 7.22 (dd, 1H, J= 3.0, 5.0 Hz),
6.89 (s, 2H); Anal. Calcd for Anal. Calcd for C12H10N2O4S,
C = 51.79, H = 3.62, N = 10.07, Found C = 59.78,
H = 3.63, N = 10.09; EI MS m/z (% rel. abund.): 278.
2.2.2.5. (E)-N0-(4-ﬂuorobenzylidene)-3,4,5-trihydroxybenzohy-
drazide (5). Yield: 86%. m.p. 171–172 C; 1H NMR
(500 MHz, DMSO-d6): d 11.60 (s, 1H, NH), 9.80 (br. s, 3H,
OH), 8.37 (s, 1H, N‚CHAAr), 7.78 (t, 2 H, J= 5.5 Hz),
7.33 (t, 1H, J= 6.0 Hz), 6.91 (s, 2H); Anal. Calcd for Anal.
Calcd for C14H11FN2O4, C = 57.93, H = 3.82, N = 9.65,
Found C = 57.94, H = 3.83, N = 9.67; EI MS m/z (% rel.
abund.): 290.
2.2.2.6. (E)-N’-(furan-2-ylmethylene)-3,4,5-trihydroxybenzo-
hydrazide (6). Yield: 81%. m.p. 178–179 C; 1H NMR
(500 MHz, DMSO-d6): d 11.42 (s, 1H, NH), 9.70 (br. s, 3H,
OH), 8.42 (s, 1H, N‚CHAAr), 7.60 (d, 1H, J= 6.0 Hz),
7.35 (d, 1H, J= 4.0 Hz), 7.41 (d, 1H, J= 3.0 Hz), 7.10 (dd,
1H, J= 4.0, 6.0 Hz), 6.92 (s, 2H); Anal. Calcd for Anal.
Calcd for C12H10N2O5, C = 54.97, H = 3.84, N = 10.68,Please cite this article in press as: Taha, M. et al., Synthesis of 3,4,5-trihydroxybenzoh
Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.036Found C = 54.96, H = 3.84, N = 10.69; EI MS m/z (% rel.
abund.): 262.2.2.2.7. (E)-3,4,5-trihydroxy-N0-(3-methylbenzylidene)benzo-
hydrazide (7). Yield: 83%. m.p. 175–176 C; 1H NMR
(500 MHz, DMSO-d6): d 11.51 (s, 1H, NH), 9.42 (br. s, 3H,
OH), 8.42 (s, 1H, N‚CHAAr), 7.52 (s, 1H), 7.48 (d, 1H,
J= 7.5 Hz), 7.35 (t, 1H, J= 7.5 Hz), 7.10 (d, 1H,
J= 8.0 Hz), 6.93 (s, 2H), 2.36 (3H, CH3); Anal. Calcd for
Anal. Calcd for C15H14N2O4, C = 62.93, H = 4.93,
N = 9.79, Found C = 62.94, H = 3.94, N = 9.81; EI MS
m/z (% rel. abund.): 286.
2.2.2.8. (E)-3,4,5-trihydroxy-N0-(3-hydroxy-4-methoxybenzyli-
dene)benzohydrazide (8). Yield: 88%. m.p. 172–173 C; 1H
NMR (500 MHz, DMSO-d6): d 11.34 (s, 1H, NH), 9.51 (br.
s, 3H, OH), 9.21 (s, 1H, OH), 8.25 (s, 1H, N‚CHAAr),
7.23 (s, 1H), 7.03 (d, 1H, J= 8.5 Hz), 6.97 (t, 1H,
J= 8.5 Hz), 6.90 (s, 2H), 3.86 (3H, OCH3); Anal. Calcd for
Anal. Calcd for C15H14N2O6, C = 56.60, H = 4.43,
N = 8.80, Found C = 56.62, H = 4.44, N = 8.82; EI MS
m/z (% rel. abund.): 318.2.2.2.9. (E)-3,4,5-trihydroxy-N0-(pyridin-4-ylmethylene)benzo-
hydrazide (9). Yield: 90%. m.p. 174–175 C; 1H NMR
(500 MHz, DMSO-d6): d 11.48 (s, 1H, NH), 10.54 (s, 1H,
OH), 9.70 (br. s, 2H, OH), 8.79 (d, 2H, J= 6.0 Hz), 8.35 (s,
1H, N‚CHAAr), 7.66 (d, 2H, J= 6.0, Hz), 6.93 (s, 2H);
Anal. Calcd for Anal. Calcd for C13H11N3O4, C = 57.14,
H = 4.06, N = 15.38, Found C = 57.16, H = 4.09,
N = 15.36; EI MS m/z (% rel. abund.): 273.ydrazone and evaluation of their urease inhibition potential. Arabian Journal of
Synthesis of 3,4,5-trihydroxybenzohydrazone and evaluation of inhibition potential 72.2.2.10. (E)-3,4,5-trihydroxy-N0-(2-nitrobenzylidene)benzohy-
drazide (10). Yield: 87%. m.p. 170–171 C; 1H NMR
(500 MHz, DMSO-d6): d 11.92 (s, 1H, NH), 9.84 (br. s, 3H,
OH), 8.82 (s, 1H, N‚CHAAr), 8.13 (d, 1H, J= 7.5 Hz),
8.08 (dd, 1H, J= 2.0, 7.0 Hz), 7.89 (t, 1H, J= 7.5 Hz), 7.68
(ddd, 1H, J= 7.5, 2.0, 2.0 Hz), 6.92 (s, 2H); Anal. Calcd for
Anal. Calcd for C14H11N3O6, C = 53.00, H = 3.49,
N = 13.24, Found C = 53.02, H = 3.50, N = 13.26; EI MS
m/z (% rel. abund.): 317.
2.2.2.11. (E)-3,4,5-trihydroxy-N0-(3-nitrobenzylidene)benzohy-
drazide (11). Yield: 92%. m.p. 171–172 C; 1H NMR
(500 MHz, DMSO-d6): d 11.79 (s, 1H, NH), 9.74 (br. s, 3H,
OH), 8.52 (s, 1H), 8.46 (s, 1H, N‚CHAAr), 8.26 (dd, 1H,
J= 6.5, 2.0 Hz), 8.13 (d, 1H, J= 7.5 Hz), 7.77 (t, 1H,
J= 8.0 Hz), 6.95 (s, 2H); Anal. Calcd for Anal. Calcd for
C14H11N3O6, C = 53.00, H = 3.49, N = 13.24, Found
C = 53.01, H = 3.51, N = 13.25; EI MS m/z (% rel. abund.):
317.
2.2.2.12. (E)-N0-(4-chlorobenzylidene)-3,4,5-trihydroxybenzo-
hydrazide (12). Yield: 90%. m.p. 180–181 C; 1H NMR
(500 MHz, DMSO-d6): d 11.60 (s, 1H, NH), 9.65 (br. s, 3H,
OH), 8.35 (s, 1H, N‚CHAAr), 7.74 (d, 2H, J= 8.0 Hz),
7.50 (d, 2H, J= 8.0, Hz), 6.90 (s, 2H); Anal. Calcd for
Anal. Calcd for C14H11ClN2O4, C = 54.83, H = 3.62,
N = 9.13, Found C = 54.84, H = 3.61, N = 9.14; EI MS
m/z (% rel. abund.): 308 (M+ 2, 20), 306 (M+, 60).
2.2.2.13. (E)-3,4,5-trihydroxy-N0-(4-methylbenzylidene)benzo-
hydrazide (13). Yield: 87%. m.p. 177–178 C; 1H NMR
(500 MHz, DMSO-d6): d 11.44 (s, 1H, NH), 9.80 (br. s, 3H,
OH), 8.33 (s, 1H, N‚CHAAr), 7.60 (d, 2H, J= 8.0 Hz),
7.27 (d, 2H, J= 8.0, Hz), 6.90 (s, 2H), 2.33 (3H, CH3);
Anal. Calcd for Anal. Calcd for C15H14N2O4, C = 62.93,
H = 4.93, N = 9.79, Found C = 62.94, H = 4.92,
N = 9.80; EI MS m/z (% rel. abund.): 286.
2.2.2.14. (E)-N0-(3-ﬂuorobenzylidene)-3,4,5-trihydroxybenzo-
hydrazide (14). Yield: 80%. m.p. 175–176 C; 1H NMR
(500 MHz, DMSO-d6): d 11.63 (s, 1H, NH), 9.70 (br. s, 3H,
OH), 8.37 (s, 1H, N‚CHAAr), 7.54–7.46 (m, 3 H), 7.33 (td,
1H, J= 6.5, 2.0 Hz), 6.91 (s, 2H); Anal. Calcd for Anal.
Calcd for C14H11FN2O4, C = 57.93, H = 3.82, N = 9.65,
Found C = 57.95, H = 3.81, N = 9.66; EI MS m/z (% rel.
abund.): 290.
2.2.2.15. (E)-3,4,5-trihydroxy-N0-(2-methylbenzylidene)benzo-
hydrazide (15). Yield: 82%. m.p. 169–170 C; 1H NMR
(500 MHz, DMSO-d6): d 11.40 (s, 1H, NH), 9.60 (br. s, 3H,
OH), 8.69 (s, 1H, N‚CHAAr), 7.85 (d, 1H, J= 7.5 Hz),
7.31–7.23 (m, 3H), 6.92 (s, 2H), 2.35 (3H, CH3); Anal. Calcd
for Anal. Calcd for C15H14N2O4, C = 62.93, H = 4.93,
N = 9.79, Found C = 62.94, H = 4.94, N = 9.81; EI MS
m/z (% rel. abund.): 286.
2.2.2.16. (E)-3,4,5-trihydroxy-N0-(3-hydroxybenzylidene)ben-
zohydrazide (16). Yield: 90%. m.p. 172–173 C; 1H NMR
(500 MHz, DMSO-d6): d 11.47 (s, 1H, NH), 10.21 (s, 1H,
OH), 9.74 (br. s, 3H, OH), 8.32 (s, 1H, N‚CHAAr), 7.26 (t,
1H, J= 8.0 Hz), 7.16 (s, 1H), 7.07 (d, 1H, J= 8.0 Hz), 6.92
(s, 2H), 7.16 (dd, 1H, J= 8.0, 2.0 Hz); Anal. Calcd forPlease cite this article in press as: Taha, M. et al., Synthesis of 3,4,5-trihydroxybenzoh
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N = 9.72, Found C = 58.34, H = 4.21, N = 9.71; EI MS
m/z (% rel. abund.): 288.
2.2.2.17. (E)-3,4,5-trihydroxy-N0-(3-methoxybenzylidene)ben-
zohydrazide (17). Yield: 82%. m.p. 170–171 C; 1H NMR
(500 MHz, DMSO-d6): d 11.53 (s, 1H, NH), 9.74 (br. s, 3H,
OH), 8.33 (s, 1H, N‚CHAAr), 7.26 (t, 1H, J= 7.5 Hz),
7.30 (s, 1H), 7.26 (d, 1H, J= 8.0 Hz), 6.99 (dd, 1H, J= 8.0,
2.0 Hz) 6.91 (s, 2H), (s, 3H, OCH3); Anal. Calcd for Anal.
Calcd for C15H14N2O5, C = 59.60, H = 4.67, N = 9.27,
Found C = 59.61, H = 4.66, N = 9.28; EI MS m/z (% rel.
abund.): 302.
2.2.2.18. (E)-N0-(2-ﬂuorobenzylidene)-3,4,5-trihydroxybenzo-
hydrazide (18). Yield: 90%. m.p. 171–172 C; 1H-NMR
(500 MHz, DMSO-d6): d 11.68 (s, 1H, NH), 9.50 (br. s, 3H,
OH), 8.66 (s, 1H, N‚CHAAr), 7.92 (t, 3 H, J= 6.5 Hz),
7.48–7.46 (m, 1H), 7.31–7.26 (m, 2H), 6.94 (s, 2H); Anal.
Calcd for Anal. Calcd for C14H11FN2O4, C = 57.93,
H = 3.82, N = 9.65, Found C = 57.94, H = 3.83,
N = 9.64; EI MS m/z (% rel. abund.): 290.
2.2.2.19. (E)-Methyl 4-((2-(3,4,5-trihydroxybenzo)hydra-
zono)methyl)benzoate (19). Yield: 92%. m.p. 180–181 C;
1H NMR (500 MHz, DMSO-d6): d 11.60 (s, 1H, NH), 9.40
(br. s, 3H, OH), 8.36 (s, 1H, N‚CHAAr), 8.20 (d, 2H,
J= 8.0 Hz), 7.84 (d, 2H, J= 8.0, Hz), 6.91 (s, 2H), 3.80
(3H, OCH3); Anal. Calcd for Anal. Calcd for C16H14N2O6,
C = 58.18, H = 4.27, N = 8.48, Found C = 58.19,
H = 4.28, N = 8.49; EI MS m/z (% rel. abund.): 314.
2.2.3. Urease assay and inhibition
The reaction mixtures, comprising 25 lL of enzyme (jack bean
urease) solution and 55 lL of buffers containing 100 mM urea,
were incubated with 5 lL of the test compounds (0.5 mM
concentration) at 30 C for 15 min in 96-well plates. For the
kinetics assessment the urea concentrations were changed from
2 to 24 mM. Urease activity was determined by measuring
ammonia production using the indophenol method as
described by Weatherburn (1967). Brieﬂy, 45 lL of phenol
reagent (1% w/v phenol and 0.005% w/v sodium nitroprus-
side) and, 70 lL of alkali reagent (0.5% w/v NaOH and
0.1% active chloride NaOCl) were added to each well. The
increasing absorbance at 630 nm was measured after 50 min,
using a microplate reader (Molecular Device, USA). All reac-
tions were performed in triplicate in a ﬁnal volume of 200 lL.
The results (change in absorbance per min) were processed by
using SoftMaxPro software (molecular Device, USA). The
entire assays were performed at pH 6.8. Percentage inhibition
was calculated from the formula 100-(ODtest
well/ODcontrol) · 100. Thiourea was used as the standard inhibi-
tor for urease (Khan et al., 2014d).
3. Results and discussion
3.1. Chemistry
In the continuation of our research on enzyme inhibition
(Rahim et al., 2015a,b; Taha et al., 2015d; Abdullah et al.,
2015; Khan et al., 2014e) 3,4,5-trihydroxybenzohydrazonesydrazone and evaluation of their urease inhibition potential. Arabian Journal of
8 M. Taha et al.(1–19) were synthesized from 3,4,5-trihydroxybenzohydrazide
which were obtained from methyl 3,4,5-trihydroxybenzoate
by reﬂuxing with hydrazine hydrate for 4 h. The 3,4,5-
trihydroxybenzohydrazide obtained was recrystallized from
methanol. 3,4,5-Trihydroxybenzohydrazones were prepared
by reﬂuxing 3,4,5-trihydroxybenzohydrazide with differently
substituted aldehydes 1–19 in methanol for 3–4 h (Scheme 1).
The crude products obtained were recrystallized in methanol
and mostly needle like crystals were obtained in 74–87% yield.
The structures of 3,4,5-trihydroxybenzohydrazones were
deduced by using various spectroscopic techniques and CHN
analyses.
Table 1 Derivatives of 3,4,5-Trihydroxybenzohydrazone
1–19.
O
N
H
N R
HO
OH
HO3.2. Urease inhibition
In the continuation of our work, on enzyme inhibition we syn-
thesized 1–19 3,4,5-trihydroxybenzohydrzones. They were
evaluated for urease inhibition. The compounds 16, 6, 18, 14
and 10 showed good activities. The compounds 1, 4, 7, 5, 11
and 9, 3, 19 showed moderate activities while, compounds 8,
12, 15, 13 and 17 showed weak activity (Table 1).
The compound 16 (IC50 = 27.20 ± 1.2 lM)was found to be
the most active among the series of nineteen compounds. It was
found that this activity is due to the hydroxyl group present at
the 3’ position and this was conﬁrmed by compound 17
(IC50 = 83.20 ± 2.2 lM) in which hydroxyl group is replaced
bymethoxy substituent which resulted in the decrease of activity
by almost 3-fold. Compound 8 (IC50 = 50.80 ± 1.9 lM) hav-
ing 30-hydroxy-40-methoxy showed less activity than compound
16. This might be due to the bulkymethoxy group at 4’-position,
which causes compound 8 to become structurally non-
compatible toward urease enzyme. The compound 2
(IC50 = 57.40 ± 2.2 lM) having 40-methoxy showed only weak
activity further proved the signiﬁcance of hydroxy at position 3’.
The compound 6 (IC50 = 28.90 ± 1.2 lM) was found to be
the second most active compound of the series and its activity
is due to the furan ring which would be having interaction with
enzyme.
Compound 4 (IC50 = 38.40 ± 1.4 lM), which is a thio-
phene derivative, showed less activity as compared to the com-
pound 6 (consists of furan ring) and this may be due to large
size and low electronegative nature of sulfur as compared to
oxygen. Higher electronegativity effect of oxygen allows
furan-containing derivative 6 to bind better through hydrogen
bonding with urease enzyme as compared to thiophene moiety
of compound 4.
Among the pyridine derivatives, compound 9
(IC50 = 42.80 ± 1.5 lM), which is 40-pyridinyl derivative,
showed good activity as compared to its positional isomer
20-pyridene analogue 3 (IC50 = 47.40 ± 1.8 lM).
The compound 18 (IC50 = 30.10 ± 1.2 lM) having ﬂuo-
rine atom at 20-postion and compound 14Please cite this article in press as: Taha, M. et al., Synthesis of 3,4,5-trihydroxybenzoh
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showed similar activity while interestingly its other positional
isomer compound 5 (IC50 = 39.70 ± 1.4 lM), having ﬂuorine
atom at 40-postion, exhibited slightly lower reactivity.
Therefore, the order of reactivity of ﬂuorinated derivative
was found to be 20-F > 30-F > 40-F.
Other halogen substituted, compounds 1
(IC50 = 37.30 ± 1.4 lM) and 12 (IC50 = 53.90 ± 1.8 lM)
exhibited the same activity trend, such as, 30-Cl > 40-Cl. The
compound 10 (IC50 = 30.80 ± 1.2 lM) having 20-nitro
substituent showed good activity but its other isomer having
30-nitro showed weak activity.
The compound 7 having 30-methyl showed good activity as
compared to its other analogues having 20-methyl, compound
15 (IC50 = 54.00 ± 1.8 lM) and 40-methyl (compound 13
IC50 = 55.40 ± 1.9 lM). Their order of reactivity was found
to be 30-methyl > 20-methyl > 40-methyl, while the compound
19 (IC50 = 48.80 ± 1.6 lM) having ester group showed mod-
erate activity.
To investigate the inhibition mechanism of this series, the
kinetic studies on ﬁve most active compounds 6, 10, 14, 16
and 18 were performed, with different concentrations of test
compounds and substrates. Enzyme reaction is the ﬁrst order
reaction and the enzyme kinetics were used for only the deter-
mination of type of inhibition and Ki value. From kinetic stud-
ies, it was inferred that compounds 6 and 16 are competitive
inhibitors with Ki values 19.1 ± 0.007 and 10.53 ± 0.02 lM,
respectively (Figs. 1 and 2). The type of inhibition was deter-
mined by Lineweaver–Burk plots. The reciprocal of the rate
of the reaction was plotted against the reciprocal of substrate
concentration to monitor the effect of inhibitor on both Km
and Vmax. Figs. 1 and 2 showed that in the presence of com-
pounds 6 and 16, the Vmax of jack bean urease enzyme was
not affected, while the Km of enzyme increased, which indicates
the competitive inhibition (Table 2).
The secondary replots of Lineweaver–Burk plots (Lodhi
et al., 2007; Muhammad Et al., 2014) were plotted to deter-
mine the Ki value (Fig. 2). The Ki values were calculated by
plotting the slope of each line in the Lineweaver–Burk plots
against different concentrations of compounds 6 and 16. The
Ki value was conﬁrmed from Dixon plot, by plotting the recip-
rocal of the rate of reaction against the different concentra-
tions of compounds 6 and 16.
The kinetic studies of compounds 10, 14 and 18 indicated
that these are mixed-type of inhibitors with Ki values between
18.41 and 21.71 lM (Figs. 3–5). The Lineweaver–Burk plots of
compounds 10, 14 and 18 showed that in the presence of com-
pounds 10, 14 and 18, both the Vmax and Km of jack bean
urease were affected. In the presence of compounds 10, 14
and 18 the Vmax of jack bean urease was decreased, while the
Km was increased, which indicated the mixed-type of inhibi-
tion. Again for Ki determination of compounds 10, 14 and
18 the secondary replots of Lineweaver–Burk plots and
Dixon plot were used.4. Difference in IR and NMR data responsible for inhibition
activity
The ﬁrst ring of compounds (1–19) is common. The variation
in inhibition potential is mainly due to the functional group
present on second ring. We can easily distinguish by IR andydrazone and evaluation of their urease inhibition potential. Arabian Journal of
Synthesis of 3,4,5-trihydroxybenzohydrazone and evaluation of inhibition potential 9NMR by observing the pick of functional group. In case of
NMR inactive functional group we can see the variation in
Chemical shift of adjacent Proton Table 3.
O
N
H
N
HO
OH
HO
R5. Conclusion
In this study, we synthesized 3,4,5-trihydroxybenzohydrazones
(1–19) and evaluated them for their urease inhibition activity.
The results for urease inhibition showed excellent activity,
close to the standard thiourea. We found new class of urease
inhibitors. The kinetic studies on the ﬁve most active com-
pounds 6, 10, 14, 16 and 18 were carried out. The compounds
6 and 16 were found to be competitive inhibitors and the com-
pounds 10, 14 and 18 were found to be mixed-type of
inhibitors.
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